The largest database of trusted experimental protocols

Silencerselect pre designed sirna for nrf2

Manufactured by Thermo Fisher Scientific
Sourced in United States

The SilencerSelect Pre-designed siRNA for Nrf2 is a laboratory product designed to target and silence the Nrf2 gene, which plays a role in cellular stress response. This siRNA is pre-designed and optimized to effectively downregulate Nrf2 expression in experimental settings.

Automatically generated - may contain errors

2 protocols using silencerselect pre designed sirna for nrf2

1

Silencing Nrf2 in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silencer
Select Pre-designed siRNA for Nrf2 and negative control siRNA were
obtained from Ambion (Life Technologies, Carlsbad, CA, USA). The target
sequences for the Nrf2 siRNAs were 5′-GAAUGGUCCUAAAACACCATT-3′
(sense) and 5′-UGGUGUUUUAGGACCAUUCTG-3′ (antisense).
Reverse transfections of siRNAs into HepG2 cells were performed using
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s protocol. In brief, HepG2 cells were maintained
in antibiotic-free medium. Each siRNA was diluted with Opti-MEM I
Reduced Serum Medium (Gibco, Carlsbad, CA, USA) and added along with
Lipofectamine RNAiMAX to a single well of a 6-well plate. After 20
min of incubation at room temperature, a suspension of 2.5 ×
105 HepG2 cells was added to obtain a 2 nM final siRNA
concentration. After 48 h of incubation, the medium was replaced with
fresh medium with or without OP60, and cells were further incubated
for 24 h. Cells were then harvested for the measurement of GSH and
total RNA preparation. The efficiency of siRNA knockdown of Nrf2 was
determined by real-time PCR.
+ Open protocol
+ Expand
2

Nrf2 Knockdown in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA transfection was conducted as previously described.‍(23 (link)) Silencer select pre-designed siRNA for Nrf2 and negative control siRNA were purchased from Ambion (Life Technologies, Carlsbad, CA). The target sequences for the Nrf2 siRNAs were 5-GAAUGGUCCUAAAACACCATT-3 (sense) and 5-UGGUGUUUUAGGACCAUUCTG-3 (antisense). Reverse transfection of siRNAs into HepG2 cells was performed using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions. Each siRNA was diluted with Opti-MEM I Reduced Serum Medium (Gibco, Carlsbad, CA), and Lipofectamine RNAiMAX was added to 6-well plate. After 20 min of incubation at room temperature (23–25°C), a suspension of 2.5 × 10‍5 cells/well was added to obtain a final siRNA concentration of 10 μM. After 48 h of incubation, the medium was replaced with fresh medium with or without 6 μM identified peptide. Cells were harvested for 24 h to measure HO-1 and Nrf2 expression. The efficiency of Nrf2 knockdown was confirmed by real-time PCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!